Table 7.
Post-operative pancreatitis after stent implantation
| Study | Reference | Type of study | USEMS | CSEMS | P-value |
|---|---|---|---|---|---|
| Omata et al. (2004) | [8] | RCT | 1/55 (1.8%) | 5/57 (8.8%) | ns |
| Seo et al. (2019) | [20] | RCT | 0/60 (0.0%) | 1/59 (1.7%) | 0.5 |
| Jang et al. (2018) | [26] | Retrospective study | 21/431 (4.9%) | 11/214 (5.1%) | 0.88 |
| Sakai et al. (2021) | [11] | RCT | 2/48 (4.2%) | 0/44 (0.0%) | 0.496 |
| Lee et al. (2013) | [12] | Retrospective study | 6/578 (1.0%) | 10/171 (5.8%) | <0.001 |
| Kullman et al. (2010) | [13] | RCT | 4/200 (2.0%) | 3/200 (1.5%) | >0.5 |
| Kawakubo et al. (2011) | [15] | Retrospective study | 0/21 (0.0%) | 6/44 (13.6%) | 0.026 |
| Yamashita et al. (2022) | [18] | META | OR (CSEMS vs USEMS) = 1.22 | ns | |
| Saleem et al. (2011) | [19] | META | RR (CSEMS vs USEMS) = 1.27 | P = 0.77, I2 = 42% | |
| Tringali et al. (2018) | [22] | META | OR (CSEMS vs USEMS) = 1.22 | ns | |
USEMS, uncovered self-expanding metal stent; CSEMS, covered self-expanding metal stent; RCT, randomized–controlled trial; META, meta-analysis; OR, odds ratio; RR, relative risk; ns, not significant.